These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 10940284)

  • 1. Topical tacrolimus may be effective in the treatment of oral and perineal Crohn's disease.
    Casson DH; Eltumi M; Tomlin S; Walker-Smith JA; Murch SH
    Gut; 2000 Sep; 47(3):436-40. PubMed ID: 10940284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical tacrolimus in the treatment of perianal Crohn's disease: exploratory randomized controlled trial.
    Hart AL; Plamondon S; Kamm MA
    Inflamm Bowel Dis; 2007 Mar; 13(3):245-53. PubMed ID: 17206671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical tacrolimus 0.1% ointment for treatment of cutaneous Crohn's Disease.
    Rice SA; Woo PN; El-Omar E; Keenan RA; Ormerod AD
    BMC Res Notes; 2013 Jan; 6():19. PubMed ID: 23331739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral tacrolimus (FK 506) in Crohn's disease complicated by fistulae of the perineum.
    Ierardi E; Principi M; Rendina M; Francavilla R; Ingrosso M; Pisani A; Amoruso A; Panella C; Francavilla A
    J Clin Gastroenterol; 2000 Mar; 30(2):200-2. PubMed ID: 10730928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preliminary report on the use of oral tacrolimus (FK506) in the treatment of complicated proximal small bowel and fistulizing Crohn's disease.
    Sandborn WJ
    Am J Gastroenterol; 1997 May; 92(5):876-9. PubMed ID: 9149205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic review: the role of tacrolimus in the management of Crohn's disease.
    McSharry K; Dalzell AM; Leiper K; El-Matary W
    Aliment Pharmacol Ther; 2011 Dec; 34(11-12):1282-94. PubMed ID: 21999607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral graft vs. host disease in children--treatment with topical tacrolimus ointment.
    Albert MH; Becker B; Schuster FR; Klein B; Binder V; Adam K; Nienhoff C; Führer M; Borkhardt A
    Pediatr Transplant; 2007 May; 11(3):306-11. PubMed ID: 17430488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination therapy with oral tacrolimus (FK506) and azathioprine or 6-mercaptopurine for treatment-refractory Crohn's disease perianal fistulae.
    Lowry PW; Weaver AL; Tremaine WJ; Sandborn WJ
    Inflamm Bowel Dis; 1999 Nov; 5(4):239-45. PubMed ID: 10579116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Steroid-unresponsive acute attacks of inflammatory bowel disease: immunomodulation by tacrolimus (FK506).
    Fellermann K; Ludwig D; Stahl M; David-Walek T; Stange EF
    Am J Gastroenterol; 1998 Oct; 93(10):1860-6. PubMed ID: 9772045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three times weekly tacrolimus ointment reduces relapse in stabilized atopic dermatitis: a new paradigm for use.
    Paller AS; Eichenfield LF; Kirsner RS; Shull T; Jaracz E; Simpson EL;
    Pediatrics; 2008 Dec; 122(6):e1210-8. PubMed ID: 19015204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tacrolimus for the treatment of fistulas in patients with Crohn's disease: a randomized, placebo-controlled trial.
    Sandborn WJ; Present DH; Isaacs KL; Wolf DC; Greenberg E; Hanauer SB; Feagan BG; Mayer L; Johnson T; Galanko J; Martin C; Sandler RS
    Gastroenterology; 2003 Aug; 125(2):380-8. PubMed ID: 12891539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic absorption with complications during topical tacrolimus treatment for orofacial Crohn disease.
    Russell RK; Richardson N; Wilson DC
    J Pediatr Gastroenterol Nutr; 2001 Feb; 32(2):207-8. PubMed ID: 11321395
    [No Abstract]   [Full Text] [Related]  

  • 13. Topical tacrolimus and Crohn disease.
    Hodgson T; Hegarty A; Porter S
    J Pediatr Gastroenterol Nutr; 2001 Nov; 33(5):633. PubMed ID: 11740245
    [No Abstract]   [Full Text] [Related]  

  • 14. Oral tacrolimus treatment of severe colitis in children.
    Bousvaros A; Kirschner BS; Werlin SL; Parker-Hartigan L; Daum F; Freeman KB; Balint JP; Day AS; Griffiths AM; Zurakowski D; Ferry GD; Leichtner AM
    J Pediatr; 2000 Dec; 137(6):794-9. PubMed ID: 11113835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral tacrolimus long-term therapy in patients with Crohn's disease and steroid resistance.
    Ierardi E; Principi M; Francavilla R; Pisani A; Rendina M; Ingrosso M; Guglielmi FW; Panella C; Francavilla A
    Aliment Pharmacol Ther; 2001 Mar; 15(3):371-7. PubMed ID: 11207512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significant absorption of topical tacrolimus in 3 patients with Netherton syndrome.
    Allen A; Siegfried E; Silverman R; Williams ML; Elias PM; Szabo SK; Korman NJ
    Arch Dermatol; 2001 Jun; 137(6):747-50. PubMed ID: 11405764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective evaluation of anti-tumor necrosis factor therapy guided by magnetic resonance imaging for Crohn's perineal fistulas.
    Ng SC; Plamondon S; Gupta A; Burling D; Swatton A; Vaizey CJ; Kamm MA
    Am J Gastroenterol; 2009 Dec; 104(12):2973-86. PubMed ID: 19755971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of tacrolimus (FK-506) on Japanese patients with refractory Crohn's disease.
    Tamaki H; Nakase H; Matsuura M; Inoue S; Mikami S; Ueno S; Uza N; Kitamura H; Kasahara K; Chiba T
    J Gastroenterol; 2008; 43(10):774-9. PubMed ID: 18958546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Efficiency of tacrolimus therapy for perianal Crohn's disease].
    Nanaeva BA; Vardanyan AV; Khalif IL
    Ter Arkh; 2015; 87(6):83-87. PubMed ID: 26281201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tacrolimus salvage in anti-tumor necrosis factor antibody treatment-refractory Crohn's disease.
    Gerich ME; Pardi DS; Bruining DH; Kammer PP; Becker BD; Tremaine WT
    Inflamm Bowel Dis; 2013 May; 19(6):1107-11. PubMed ID: 23518805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.